reglab/housing_qa huggingface dataset:
SD Codified L § 34-20A-109 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20A - Treatment And Prevention Of Alcohol And Drug Abuse|Section 34-20A-109 - Definitions related to reporting person in need of emergency assistance for drug-related overdose.

34-20A-109. Definitions related to reporting person in need of emergency assistance for drug-related overdose.Terms used in §§34-20A-110 to 34-20A-113, inclusive, mean:(1)"Drug-related overdose," an acute condition, including mania, hysteria, extreme physical illness, coma, or death resulting from the consumption or use of a controlled substance, or another substance with which a controlled substance was combined, and that a person would reasonably believe to be a drug overdose that requires medical assistance. Source: SL 2017, ch 154, §1.
SD Codified L § 34-20A-110 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20A - Treatment And Prevention Of Alcohol And Drug Abuse|Section 34-20A-110 - Immunity from arrest or prosecution for reporting person in need of emergency medical assistance for drug-related overdose.

34-20A-110. Immunity from arrest or prosecution for reporting person in need of emergency medical assistance for drug-related overdose.No person may be arrested or prosecuted for any misdemeanor or felony offense of possession, inhalation, ingestion, or otherwise taking into the body any controlled drug or substance if that person contacts any law enforcement or emergency medical services and reports that a person is in need of emergency medical assistance as the result of a drug-related overdose. A person qualifies for the immunities provided in §§34-20A-109 to 34-20A-113, inclusive, only if:(1)The evidence for the charge or prosecution was obtained as a result of the person seeking medical assistance for another person;(2)The person seeks medical assistance for another person who is in need of medical assistance for an immediate health or safety concern; and(3)The person seeking medical assistance for another person remains on the scene and cooperates with medical assistance and law enforcement personnel. Source: SL 2017, ch 154, §2.
SD Codified L § 34-20A-111 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20A - Treatment And Prevention Of Alcohol And Drug Abuse|Section 34-20A-111 - Immunity from arrest or prosecution for reporting one's own need for emergency medical assistance for drug-related overdose.

34-20A-111. Immunity from arrest or prosecution for reporting one's own need for emergency medical assistance for drug-related overdose.A person who experiences a drug-related overdose and is in need of medical assistance may not be arrested, charged, or prosecuted for any misdemeanor or felony offense of possession, inhalation, ingestion, or otherwise taking into the body any controlled drug or substance if that person contacts law enforcement or emergency medical services and reports that he or she is in need of medical assistance as the result of a drug-related overdose. A person qualifies for the immunities provided in this section only if the evidence for the charge or prosecution was obtained as a result of the drug-related overdose and the need for medical assistance. Source: SL 2017, ch 154, §3.
SD Codified L § 34-20A-112 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20A - Treatment And Prevention Of Alcohol And Drug Abuse|Section 34-20A-112 - Providing first aid or other medical assistance as mitigating factor--Limitations on immunity.

34-20A-112. Providing first aid or other medical assistance as mitigating factor--Limitations on immunity.Providing first aid or other medical assistance to someone who is experiencing a drug-related overdose may be used as a mitigating factor in a criminal prosecution for which immunity is not provided under §§34-20A-109 to 34-20A-113, inclusive. Nothing in §§34-20A-109 to 34-20A-113, inclusive, may be construed to:(1)Bar the admissibility of any evidence obtained in connection with the investigation and prosecution of other crimes or violations committed by a person who otherwise qualifies for limited immunity pursuant to §§34-20A-109 to 34-20A-113, inclusive; or(2)Limit, modify, or remove any immunity from liability currently available to public entities, public employees by law, or prosecutors. Source: SL 2017, ch 154, §4.
SD Codified L § 34-20A-113 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20A - Treatment And Prevention Of Alcohol And Drug Abuse|Section 34-20A-113 - One-time immunity.

34-20A-113. One-time immunity.Any person seeking medical assistance or who reports a person is in need of medical assistance shall only qualify once for immunity under §§34-20A-109 to 34-20A-112, inclusive. Source: SL 2017, ch 154, §5.
SD Codified L § 34-20B-2 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-2 - Drug defined.

34-20B-2. Drug defined.For the purposes of this chapter, unless the context otherwise requires, "drug" means:(1)Articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them, unless the department shall determine that any such article is inconsistent with the provisions of this chapter or are not appropriate to conditions which exist in this state, and by regulation specifically excludes any such article;(2)Articles intended for use, or used, in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals;(3)Articles (other than food) intended to affect, or affecting, the structure or any function of the body of man or other animals; and(4)Articles intended for use, or used, as a component of any articles specified in clauses (1), (2), or (3) of this section, but does not include mechanical devices or their components, parts, or accessories. Source: SL 1970, ch 229, §6 (j); SDCL Supp, §39-17-45.
SD Codified L § 34-20B-3 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-3 - Controlled drug or substance defined.

34-20B-3. Controlled drug or substance defined.For the purposes of this chapter, unless the context otherwise requires, "controlled drug or substance" means a drug, substance, or immediate precursor in Schedules I through IV of §§34-20B-11 to 34-20B-26, inclusive. Source: SL 1970, ch 229, §6 (e); SDL Supp, §39-17-46; SL 1976, ch 158, §42-10.
SD Codified L § 34-20B-3.1 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-3.1 - Controlled substance analogue.

34-20B-3.1. Controlled substance analogue.A controlled substance analogue shall be treated as a controlled substance in schedule I. Source: SL 2013, ch 156, §2, eff. Mar. 6, 2013.
SD Codified L § 34-20B-4 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-4 - Precursor defined.

34-20B-4. Precursor defined.For the purposes of this chapter, unless the context otherwise requires, "precursor" or "immediate precursor" means a substance which the department has found to be and by regulation designates as being a principal compound commonly used or produced primarily for use, and which is an immediate chemical intermediary used or likely to be used, in the manufacture of a controlled drug or substance, the control of which is necessary to prevent, curtail, or limit such manufacture. Source: SL 1970, ch 229, §6 (u); SDCL Supp, §39-17-47.
SD Codified L § 34-20B-10 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-10 - Scheduled substances to be controlled--Nomenclature in schedules.

34-20B-10. Scheduled substances to be controlled--Nomenclature in schedules.All controlled drugs and substances listed in §§34-20B-11 to 34-20B-26, inclusive, are hereby controlled. The schedules set forth in said sections include the controlled drugs and substances listed or to be listed, by whatever official name, common or usual name, or trade name designated. Source: SL 1970, ch 229, §§7, 8; SDCL Supp, §39-17-53.
SD Codified L § 34-20B-11 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-11 - Criteria for inclusion of substance in Schedule I.

34-20B-11. Criteria for inclusion of substance in Schedule I.To be included within Schedule I, a substance shall have:(1)A high potential for abuse;(2)No accepted medical use in the United States; and(3)A lack of accepted safety for use under medical supervision. Source: SL 1970, ch 229, §8 (a); SDCL Supp, §39-17-54; SL 1976, ch 158, §42-11.
SD Codified L § 34-20B-12 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-12 - Specific substances included in Schedule I.

34-20B-12. Specific substances included in Schedule I. Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:(1)Acetylmethadol;(2)Allylprodine;(3)Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;(4)Alphameprodine;(5)Alphamethadol;(6)Benzethidine;(7)Betacetylmethadol;(8)Betameprodine;(9)Betamethadol;(10)Betaprodine;(11)Clonitazene;(12)Dextromoramide;(13)Diampromide;(14)Diethyliambutene;(15)Dimenoxadol;(16)Dimepheptanol;(17)Dimethyliambutene;(18)Dioxaphetyl butyrate;(19)Dipipanone;(20)Ethylmethylthiambutene;(21)Etonitazene;(22)Etoxeridine;(23)Furethidine;(24)Hydroxypethidine;(25)Ketobemidone;(26)Levomoramide;(27)Levophenacylmorphan;(28)Mecloqualone;(29)Morpheridine;(30)Noracymethadol;(31)Norlevorphanol;(32)Normethadone;(33)Norpipanone;(34)Phenadoxone;(35)Phenampromide;(36)Phenomorphan;(37)Phenoperidine;(38)Piritramide;(39)Proheptazine;(40)Properidine;(41)Racemoramide;(42)Trimeperidine;(43)Methaqualone;(44)N-benzylpiperazine;(45)4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18; and(46)N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene. Source: SL 1970, ch 229, §8 (a) (1); SDCL Supp, §39-17-55; SL 1977, ch 315, §1; SL 1985, ch 278, §50; SL 1994, ch 278, §1; SL 2003, ch 183, §1; SL 2018, ch 203, §1, eff. Feb. 8, 2018; SL 2021, ch 144, § 1, eff. Feb. 17, 2021.
SD Codified L § 34-20B-15 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-15 - Criteria for inclusion of substances in Schedule II.

34-20B-15. Criteria for inclusion of substances in Schedule II.To be included within Schedule II, a substance shall have:(1)A high potential for abuse,(2)Currently accepted medical use in the United States, or currently accepted medical use with severe restrictions, and(3)Abuse which may lead to severe psychic or physical dependence. Source: SL 1970, ch 229, §8 (b); SDCL Supp, §39-17-58; SL 1976, ch 158, §42-14.
SD Codified L § 34-20B-16 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-16 - Substances included in Schedule II.

34-20B-16. Substances included in Schedule II. Any of the following substances including their salts, isomers, and salts of isomers is included in Schedule II except those narcotic drugs listed in other schedules whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:(1)Opium (except when it meets the requirements of subdivision 34-20B-23(7) or 34-20B-26(5)), coca leaves, and opiate;(2)Any salt, compound, derivative, or preparation of opium, coca leaves (including cocaine), or opiate, excluding apomorphine, dextrorphan, naloxone, naloxegol, naldemedine, nalbuphine, nalmefene, naltrexone, and 6ß-naltrexol;(3)Any salt, compound, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subdivisions (1) and (2), except that these substances may not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; and may not include the isoquinoline alkaloids of opium;(4)Opium poppy and poppy straw;(5)Amphetamine;(6)Methamphetamine;(7)Amobarbital;(8)Pentobarbital;(9)Secobarbital;(10)Methylphenidate;(11)Phenmetrazine;(12)Etorphine;(13)Diprenorphine;(14)Deleted by SL 2000, ch 170, §1;(15)Nabilone;(16)Glutethimide;(17)Phencyclidine immediate precursors:(a)1-phenylcyclohexylamine;(b)1-piperidinocyclohexanecarbonitrile (PCC);(18)Lisdexamfetamine, its salts, isomers, and salts of its isomers; (19)Tapentadol; and(20)Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration. Source: SL 1970, ch 229, §8 (b) (1); SDCL Supp, §39-17-59; SL 1977, ch 315, §4; SL 1978, ch 249, §1; SL 1981, ch 13, §9; SL 1981, ch 261, §1; SL 1985, ch 278, §51; SL 1986, ch 284; SL 1987, ch 255, §3; SL 1992, ch 245, §1; SL 1993, ch 247, §2; SL 2000, ch 170, §1; SL 2008, ch 170, §1, eff. Feb. 13, 2008; SL 2010, ch 174, §2, eff. Feb. 24, 2010; SL 2012, ch 183, §2, eff. Feb. 23, 2012; SL 2015, ch 180, §2, eff. Feb. 18, 2015; SL 2016, ch 175, §3, eff. Feb. 18, 2016; SL 2018, ch 203, §3, eff. Feb. 8, 2018; SL 2021, ch 144, § 4, eff. Feb. 17, 2021.
SD Codified L § 34-20B-17 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-17 - Opiates included in Schedule II.

34-20B-17. Opiates included in Schedule II. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:(1)Alphaprodine;(2)Anileridine;(3)Bezitramide;(4)Diphenoxylate;(5)Fentanyl;(6)Isomethadone;(7)Levomethorphan;(8)Levorphanol;(9)Metazocine;(10)Methadone;(11)Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane;(12)Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;(13)Pethidine;(14)Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine;(15)Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate;(16)Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;(17)Phenazocine;(18)Piminodine;(19)Racemethorphan;(20)Racemorphan;(21)Sufentanil;(22)Alfentanil;(23)Carfentanil;(24)Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadyl acetate or LAAM;(25)Remifentanil;(26)Oxymorphone;(27)Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol);(28)4-anilino-N-phenethylpiperidine (ANPP);(29)Morphine, except when it meets subdivision 34-20B-23(8);(30)Hydrocodone (Dihydrocodeinone);(31)Codeine, except when it meets subdivision 34-20B-23(1), 34-20B-23(2), or 34-20B-26(1);(32)Dihydrocodeine, except when it meets subdivision 34-20B-23(5) or 34-20B-26(2);(33)Ethylmorphine, except when it meets subdivision 34-20B-23(6) or 34-20B-26(3);(34)Oxycodone;(35)Hydromorphone;(36)Thiafentanil;(37)Noroxymorphone;(38)N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl); and(39)Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate). Source: SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-60; SL 1985, ch 278, § 52; SL 1987, ch 255, § 4; SL 1989, ch 293, § 3; SL 1994, ch 278, § 3; SL 2002, ch 167, § 1; SL 2007, ch 194, § 1, eff. Feb. 1, 2007; SL 2008, ch 170, § 2, eff. Feb. 13, 2008; SL 2011, ch 160, § 2, eff. Feb. 24, 2011; SL 2015, ch 180, § 3, eff. Feb. 18, 2015; SL 2017, ch 156, § 2, eff. Feb. 3, 2017; SL 2020, ch 144, § 2, eff. Mar. 9, 2020; SL 2021, ch 144, § 5, eff. Feb. 17, 2021.
SD Codified L § 34-20B-18 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-18 - Criteria for inclusion of substances in Schedule III.

34-20B-18. Criteria for inclusion of substances in Schedule III.To be included within Schedule III, a substance shall have:(1)A potential for abuse less than the substances listed in Schedules I and II;(2)Well documented and approved medical use in the United States; and(3)Abuse which may lead to moderate or low physical dependence or high psychological dependence. Source: SL 1970, ch 229, §8 (c); SDCL Supp, §39-17-61; SL 1976, ch 158, §42-15.
SD Codified L § 34-20B-19 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-19 - Stimulants specifically included in Schedule III.

34-20B-19. Stimulants specifically included in Schedule III.Any material, compound, mixture, or preparation is included in Schedule III which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:(1)Benzphetamine;(2)Chlorphentermine;(3)Phendimetrazine;(4)Ephedrine. Source: SL 1970, ch 229, §8 (c); SDCL Supp, §39-17-62; SL 1977, ch 315, §5; SL 1993, ch 247, §3; SL 1995, ch 195, §1; SL 1997, ch 202, §1.
SD Codified L § 34-20B-19.1 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-19.1 - Ephedrine defined.

34-20B-19.1. Ephedrine defined.For the purposes of §34-20B-19, the term, ephedrine includes ephedra, herbs and herbal products that contain ephedrine alkaloids, including ma huang, Chinese ephedra, ephedra sinica, ephedra herb powder, epitonin, or any extract of those substances, but the term does not include any drug that contains ephedrine and is lawfully sold, transferred, or furnished over the counter with or without a prescription pursuant to §34-20B-21. Source: SL 2004, ch 231, §1.
SD Codified L § 34-20B-20 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-20 - Depressants specifically included in Schedule III.

34-20B-20. Depressants specifically included in Schedule III.Any material, compound, mixture, or preparation is included in Schedule III that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:(1)Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules;(2)Chloral betaine;(3)Chloral hydrate;(4)Chlorhexadol;(5)Lysergic acid;(6)Lysergic acid amide;(7)Methyprylon;(8)Sulfondiethylmethane;(9)Sulfonethylmethane;(10)Sulfonmethane;(11)Amobarbital, pentobarbital, and secobarbital in suppository dosage form;(12)Gamma hydroxy butyrate;(13)Dronabinol in sesame oil and encapsulated in a gelatin capsule in a drug product approved for marketing by the United States Food and Drug Administration;(14)Buprenorphine;(15)Embutramide;(16)Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers. Source: SL 1970, ch 229, §8 (c) (1); SDCL Supp, §39-17-63; SL 1973, ch 260; SL 1979, ch 238, §2; SL 1980, ch 240, §1; SL 1992, ch 245, §2; SL 1993, ch 247, §4; SL 1999, ch 174, §1; SL 2000, ch 170, §2; SL 2003, ch 183, §3; SL 2007, ch 194, §2, eff. Feb. 1, 2007; SL 2014, ch 165, §2, eff. Feb. 10, 2014; SL 2018, ch 203, §4, eff. Feb. 8, 2018.
SD Codified L § 34-20B-20.1 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-20.1 - Gamma hydroxyl butyrate defined.

34-20B-20.1. Gamma hydroxyl butyrate defined.For the purposes of §34-20B-20, the term, gamma hydroxyl butyrate, includes gamma-butyrolactone, 1,4-butanediol or any other substances which convert to gamma hydroxyl butyrate upon ingestion. However, the term does not include any product which is lawfully used for mechanical, industrial, manufacturing, or scientific purposes. Source: SL 2006, ch 180, §1.
SD Codified L § 34-20B-21 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-21 - Exception from Schedule III of stimulants and depressants used in medicinal preparations.

34-20B-21. Exception from Schedule III of stimulants and depressants used in medicinal preparations.The department may by rules promulgated pursuant to chapter 1-26 except any compound, mixture, or preparation containing any stimulant, depressant substance, or anabolic steroid listed in §§34-20B-19, 34-20B-20, and 34-20B-22 if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant, depressant, or anabolic steroid effect. Such admixtures shall be included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a stimulant, depressant, or anabolic steroid effect. Source: SL 1970, ch 229, §8 (c); SDCL Supp, §39-17-64; SL 1993, ch 247, §5; SL 1997, ch 202, §2.
SD Codified L § 34-20B-22 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-22 - Specific substances included in Schedule III.

34-20B-22. Specific substances included in Schedule III.The following are included in Schedule III:(1)Nalorphine;(2)Preparations which contain both Tiletamine and Zolazepam;(3)Anabolic steroids as listed in §34-20B-4.1;(4)Ketamine. Source: SL 1970, ch 229, §8 (c); SDCL Supp, §39-17-65; SL 1971, ch 224, §§1, 2; SL 1988, ch 282, §3; SL 1992, ch 245, §5; SL 1993, ch 247, §6; SL 2000, ch 170, §3.
SD Codified L § 34-20B-23 (2021)
2021 South Dakota Codified Laws|Title 34 - Public Health and Safety|Chapter 20B - Drugs And Substances Control|Section 34-20B-23 - Narcotics specifically included in Schedule III.

34-20B-23. Narcotics specifically included in Schedule III.Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof is included in Schedule III:(1)Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of isoquinoline alkaloid of opium;(2)Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;(3)Deleted by SL 2015, ch 180, §4;(4)Deleted by SL 2015, ch 180, §4;(5)Not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;(6)Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;(7)Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts; and(8)Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts. Source: SL 1970, ch 229, §8 (c); SDCL Supp, §39-17-66; SL 2015, ch 180, §4, eff. Feb. 18, 2015.